Recombinant human fibroblast growth factor-21 (Wenzhou Medical University)

重组人成纤维细胞生长因子-21(温州医科大学)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human fibroblast growth factor-21 (Wenzhou Medical University)
Drug Alias NamerhFGF-21注射用重组人成纤维细胞生长因子-21
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesWenzhou Medical University
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A